158 related articles for article (PubMed ID: 31372638)
1. A CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferation.
Korkmaz G; Manber Z; Lopes R; Prekovic S; Schuurman K; Kim Y; Teunissen H; Flach K; Wit E; Galli GG; Zwart W; Elkon R; Agami R
Nucleic Acids Res; 2019 Oct; 47(18):9557-9572. PubMed ID: 31372638
[TBL] [Abstract][Full Text] [Related]
2. BAP18 facilitates CTCF-mediated chromatin accessible to regulate enhancer activity in breast cancer.
Sun G; Wei Y; Zhou B; Wang M; Luan R; Bai Y; Li H; Wang S; Zheng D; Wang C; Wang S; Zeng K; Liu S; Lin L; He M; Zhang Q; Zhao Y
Cell Death Differ; 2023 May; 30(5):1260-1278. PubMed ID: 36828916
[TBL] [Abstract][Full Text] [Related]
3. Sequential in
Amândio AR; Beccari L; Lopez-Delisle L; Mascrez B; Zakany J; Gitto S; Duboule D
Genes Dev; 2021 Nov; 35(21-22):1490-1509. PubMed ID: 34711654
[TBL] [Abstract][Full Text] [Related]
4. Enhancer release and retargeting activates disease-susceptibility genes.
Oh S; Shao J; Mitra J; Xiong F; D'Antonio M; Wang R; Garcia-Bassets I; Ma Q; Zhu X; Lee JH; Nair SJ; Yang F; Ohgi K; Frazer KA; Zhang ZD; Li W; Rosenfeld MG
Nature; 2021 Jul; 595(7869):735-740. PubMed ID: 34040254
[TBL] [Abstract][Full Text] [Related]
5. Enhancer-driven 3D chromatin domain folding modulates transcription in human mammary tumor cells.
Kocanova S; Raynal F; Goiffon I; Oksuz BA; Baú D; Kamgoué A; Cantaloube S; Zhan Y; Lajoie B; Marti-Renom MA; Dekker J; Bystricky K
Life Sci Alliance; 2024 Feb; 7(2):. PubMed ID: 37989525
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions.
Joosten SEP; Gregoricchio S; Stelloo S; Yapıcı E; Huang CF; Yavuz K; Donaldson Collier M; Morova T; Altintaş UB; Kim Y; Canisius S; Moelans CB; van Diest PJ; Korkmaz G; Lack NA; Vermeulen M; Linn SC; Zwart W
Genome Res; 2024 May; 34(4):539-555. PubMed ID: 38719469
[TBL] [Abstract][Full Text] [Related]
7. Analysis of estrogen-regulated enhancer RNAs identifies a functional motif required for enhancer assembly and gene expression.
Hou TY; Kraus WL
Cell Rep; 2022 Jun; 39(11):110944. PubMed ID: 35705040
[TBL] [Abstract][Full Text] [Related]
8. Dissecting CTCF site function in a tense HoxD locus.
Bruneau BG
Genes Dev; 2021 Nov; 35(21-22):1401-1402. PubMed ID: 34725128
[TBL] [Abstract][Full Text] [Related]
9. Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer.
Patten DK; Corleone G; Győrffy B; Perone Y; Slaven N; Barozzi I; Erdős E; Saiakhova A; Goddard K; Vingiani A; Shousha S; Pongor LS; Hadjiminas DJ; Schiavon G; Barry P; Palmieri C; Coombes RC; Scacheri P; Pruneri G; Magnani L
Nat Med; 2018 Sep; 24(9):1469-1480. PubMed ID: 30038216
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic analysis of enhancer sequences in the estrogen receptor transcriptional program.
Tabe-Bordbar S; Song YJ; Lunt BJ; Alavi Z; Prasanth KV; Sinha S
Commun Biol; 2024 Jun; 7(1):719. PubMed ID: 38862711
[TBL] [Abstract][Full Text] [Related]
11. LATS1 controls CTCF chromatin occupancy and hormonal response of 3D-grown breast cancer cells.
Ramírez-Cuéllar J; Ferrari R; Sanz RT; Valverde-Santiago M; García-García J; Nacht AS; Castillo D; Le Dily F; Neguembor MV; Malatesta M; Bonnin S; Marti-Renom MA; Beato M; Vicent GP
EMBO J; 2024 May; 43(9):1770-1798. PubMed ID: 38565950
[TBL] [Abstract][Full Text] [Related]
12. Topological reorganization and functional alteration of distinct genomic components in gallbladder cancer.
Li G; Pu P; Pan M; Weng X; Qiu S; Li Y; Abbas SJ; Zou L; Liu K; Wang Z; Shao Z; Jiang L; Wu W; Liu Y; Shao R; Liu F; Liu Y
Front Med; 2024 Feb; 18(1):109-127. PubMed ID: 37721643
[TBL] [Abstract][Full Text] [Related]
13. Systematic discovery and functional dissection of enhancers needed for cancer cell fitness and proliferation.
Chen PB; Fiaux PC; Zhang K; Li B; Kubo N; Jiang S; Hu R; Rooholfada E; Wu S; Wang M; Wang W; McVicker G; Mischel PS; Ren B
Cell Rep; 2022 Nov; 41(6):111630. PubMed ID: 36351387
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis.
Ebright RY; Lee S; Wittner BS; Niederhoffer KL; Nicholson BT; Bardia A; Truesdell S; Wiley DF; Wesley B; Li S; Mai A; Aceto N; Vincent-Jordan N; Szabolcs A; Chirn B; Kreuzer J; Comaills V; Kalinich M; Haas W; Ting DT; Toner M; Vasudevan S; Haber DA; Maheswaran S; Micalizzi DS
Science; 2020 Mar; 367(6485):1468-1473. PubMed ID: 32029688
[TBL] [Abstract][Full Text] [Related]
15. ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer.
Xu G; Chhangawala S; Cocco E; Razavi P; Cai Y; Otto JE; Ferrando L; Selenica P; Ladewig E; Chan C; Da Cruz Paula A; Witkin M; Cheng Y; Park J; Serna-Tamayo C; Zhao H; Wu F; Sallaku M; Qu X; Zhao A; Collings CK; D'Avino AR; Jhaveri K; Koche R; Levine RL; Reis-Filho JS; Kadoch C; Scaltriti M; Leslie CS; Baselga J; Toska E
Nat Genet; 2020 Feb; 52(2):198-207. PubMed ID: 31932695
[TBL] [Abstract][Full Text] [Related]
16. Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies.
Gurusamy D; Henning AN; Yamamoto TN; Yu Z; Zacharakis N; Krishna S; Kishton RJ; Vodnala SK; Eidizadeh A; Jia L; Kariya CM; Black MA; Eil R; Palmer DC; Pan JH; Sukumar M; Patel SJ; Restifo NP
Cancer Cell; 2020 Jun; 37(6):818-833.e9. PubMed ID: 32516591
[TBL] [Abstract][Full Text] [Related]
17. ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response.
Nagarajan S; Rao SV; Sutton J; Cheeseman D; Dunn S; Papachristou EK; Prada JG; Couturier DL; Kumar S; Kishore K; Chilamakuri CSR; Glont SE; Archer Goode E; Brodie C; Guppy N; Natrajan R; Bruna A; Caldas C; Russell A; Siersbæk R; Yusa K; Chernukhin I; Carroll JS
Nat Genet; 2020 Feb; 52(2):187-197. PubMed ID: 31913353
[TBL] [Abstract][Full Text] [Related]
18. A CRISPR-based base-editing screen for the functional assessment of BRCA1 variants.
Kweon J; Jang AH; Shin HR; See JE; Lee W; Lee JW; Chang S; Kim K; Kim Y
Oncogene; 2020 Jan; 39(1):30-35. PubMed ID: 31467430
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the FACT Complex Targets Aberrant Hedgehog Signaling and Overcomes Resistance to Smoothened Antagonists.
Mo J; Liu F; Sun X; Huang H; Tan K; Zhao X; Li R; Jiang W; Sui Y; Chen X; Shen K; Zhang L; Ma J; Zhao K; Tang Y
Cancer Res; 2021 Jun; 81(11):3105-3120. PubMed ID: 33853831
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-cas9 Screening Identified Lethal Genes Enriched in Cell Cycle Pathway and of Prognosis Significance in Breast Cancer.
Sun X; Wang Z; Chen X; Shen K
Front Cell Dev Biol; 2021; 9():646774. PubMed ID: 33816496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
